ET-01 in Subjects With Lateral Canthal Lines, LCL-209
Clinical trial NCT03912805 · COMPLETED
Trial details
- NCT number
- NCT03912805
- Sponsor
- Eirion Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-27
- Primary completion
- 2019-05-06
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.